|
1
|
Folkman J: Tumor angiogenesis and tissue
factor. Nat Med. 2:167–168. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ranieri G, Coviello M, Chriatti A, et al:
Vascular endothelial growth factor assessment in different blood
fractions of gastroenterology cancer patients and healthy controls.
Oncol Rep. 11:435–439. 2004.PubMed/NCBI
|
|
3
|
Ranieri G, Labriola A, Achille G, et al:
Microvessels density, mast cell density and thymidine phosphorylase
expression in oral squamous carcinoma. Int J Oncol. 21:1317–1323.
2002.PubMed/NCBI
|
|
4
|
Ranieri G, Patruno R, Lionetti A, et al:
Endothelial area and micrivascular density in a canine
non-Hodgkin's lymphoma: An interspecies model of tumor
angiogenesis. Leuk Lymphoma. 46:1639–1643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamazaki K, Nagao T, Yamaguchi T, et al:
Expression of basic fibroblast growth factor (FGF-2)-associated
with tumour proliferation in human pancreatic carcinoma. Virchows
Arch. 431:95–101. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Díaz VM, Planaguma J, Thomson TM, et al:
Tissue plasminogen activator is required for the growth, invasion
and angiogenesis of pancreatic tumor cells. Gastroenterology.
122:806–819. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumour angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soucek L, Lawlor ER, Soto D, et al: Mast
cells are required for angiogenesis and macroscopic expansion of
Myc-induced pancreatic islet tumours. Nat Med. 13:1211–1218. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang B, Fan H, Zhang IY, et al: HMGA1
expression in human gliomas and its correlation with tumor
proliferation, invasion and angiogenesis. J Neurooncol.
106:543–549. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sharma SG, Aggarwal N, Gupta SD, et al:
Angiogenesis in renal cell carcinoma: Correlation of microvessel
density and microvessel area with other prognostic factors. Int
Urol Nephrol. 43:125–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanci M, Dikis C, Inan S, et al:
Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in
leiomyoma, cellular leiomyoma and leiomyosarcoma. Acta Histochem.
113:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: Proliferation of immature tumor vessels is a novel
marker of clinical progression in prostate cancer. Cancer Res.
69:4708–4715. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koide N, Saito H, Suzuki A, et al:
Clinicopathologic features and histochemical analyses of
proliferative activity and angiogenesis in small cell carcinoma of
the esophagus. J Gastroenterol. 42:932–938. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tenderenda M: Potential prognostic value
of angiogenesis, cell proliferation and metastasing in patients
with surgically treated gastric cancer-current knowledge. Wiad Lek.
59:855–860. 2006.(In Polish). PubMed/NCBI
|
|
15
|
Imamura M, Yamamoto H, Nakamura N, et al:
Prognostic significance of angiogenesis in gastrointestinal stromal
tumor. Mod Pathol. 20:529–537. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujita S, Nagamachi S, Nishii R, et al:
Relationship between cancer cell proliferation, tumour angiogenesis
and 201Tl uptake in non-small cell lung cancer. Nucl Med Commun.
27:989–997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Zhang S, Chen YP and Lin JY:
Increased expression of angiogenin in gastric carcinoma in
correlation with tumor angiogenesis and proliferation. World J
Gastroenterol. 12:5135–5139. 2006.PubMed/NCBI
|
|
18
|
Patruno R, Zizzo N, Zito AF, et al:
Microvascular density and endothelial area correlate with Ki-67
proliferative rate in the canine non-Hodgkin's lymphoma spontaneous
model. Leuk Lymphoma. 47:1138–1143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schlüter C, Duchrow M, Wohlenberg C, et
al: The cell proliferation-associated antigen of antibody Ki-67: A
very large, ubiquitous nuclear protein with numerous repeated
elements, representing a new kind of cell cycle-maintaining
protein. J Cell Biol. 123:513–522. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalogeraki A, Tzardi M, Panagiotides I, et
al: MIB1 (Ki-67) expression in non-Hodgkin' s lymphomas. Anticancer
Res. 17:487–491. 1997.PubMed/NCBI
|
|
21
|
Stipa F, Lucandri G, Limiti MR, et al:
Angiogenesis as a prognostic indicator in pancreatic ductal
adenocarcinoma. Anticancer Res. 22:445–449. 2002.PubMed/NCBI
|
|
22
|
Karademir S, Sökmen S, Terzi C, et al:
Tumor angiogenesis as a prognostic predictor in pancreatic cancer.
J Hepatobiliary Pancreat Surg. 7:489–495. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edge SB, Byrd DR, Compton CC, et al: AJCC
Cancer Staging Manual. 7th. Springer; New York, NY: pp. 241–249.
2010
|
|
24
|
Hamilton SR and Aaltonen LA: Pathology and
Genetics. Tumours of the Digestive SystemWorld Health Organization
Classification of Tumours. International Agency for Research on
Cancer (IARC). 3rd. 2. IARC Press; Lyon, France: pp. 1–307.
2000
|
|
25
|
Ranieri G, Grammatica L, Patruno R, et al:
A possible role of thymidine phosphorylase expression and
5-fluorouracil increased sensitivity in oropharyngeal cancer
patients. J Cell Mol Med. 11:362–368. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ranieri G, Labriola A, Achille G, et al:
Microvessel density, mast cell density and thymidine phosphorylase
expression in oral squamous carcinoma. Int J Oncol. 21:1317–1323.
2002.PubMed/NCBI
|
|
27
|
Ammendola M, Sacco R, Sammarco G, et al:
Mast cells positive to tryptase and C-Kit receptor expressing cells
correlates with angiogenesis in gastric cancer patients surgically
treated. Gastroenterol Res Pract. 2013:7031632013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ammendola M, Sacco R, Donato G, et al:
Mast Cell positive to tryptase correlates with metastatic lymph
nodes in gastrointestinal cancers patients treated surgically.
Oncology. 85:111–116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma Y, Hwang RF, Logsdon CD and Ullrich SE:
Dynamic mast cell-stromal cell interactions promote growth of
pancreatic cancer. Cancer Res. 73:3927–3937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Chen X, Fang J and Yang C:
Overexpression of both VEGF-A and VEGF-C in gastric cancer
correlates with prognosis and silencing of both is effective to
inhibit cancer growth. Int J Clin Exp Pathol. 6:586–597.
2013.PubMed/NCBI
|
|
31
|
Ammendola M, Zuccalà V, Patruno R, et al:
Tryptase-positive mast cells and angiogenesis in keloids: A new
post-surgical target for prevention. Updates Surg. 65:53–57. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Patsouras D, Papaxoinis K, Kostakis A, et
al: Fibroblast activation protein and its prognostic significance
in correlation with vascular endothelial growth factor in
pancreatic adenocarcinoma. Mol Med Rep. 11:4585–4590.
2015.PubMed/NCBI
|
|
33
|
Matsuda Y, Yoshimura H, Suzuki T, et al:
Inhibition of fibroblast growth factor receptor 2 attenuates
proliferation and invasion of pancreatic cancer. Cancer Sci.
105:1212–1219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hong SP, Shin SK, Bang S, et al:
Prognostic value of thymidine phosphorylase expression for
pancreatic cancer. Hepatogastroenterology. 56:1178–1182.
2009.PubMed/NCBI
|
|
35
|
Ammendola M, Sacco R, Sammarco G, Donato
G, et al: Mast cells density positive to tryptase correlates with
angiogenesis in pancreatic ductal adenocarcinoma patients having
undergone surgery. Gastroenterol Res Pract. 2014:9519572014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ranieri G, Mammì M, Donato Di Paola E, et
al: Pazopanib a tyrosine kinase inhibitor with strong
anti-angiogenetic activity: A new treatment for metastatic soft
tissue sarcoma. Crit Rev Oncol Hematol. 89:322–329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Humbert M, Castéran N, Letard S, et al:
Masitinib combined with standard gemcitabine chemotherapy: In vitro
and in vivo studies in human pancreatic tumour cell lines and
ectopic mouse model. PLoS One. 5:e94302010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Marech I, Patruno R, Zizzo N, et al:
Masitinib (AB1010), from canine tumor model to human clinical
development: Where we are? Crit Rev Oncol Hematol. 91:98–111. 2014.
View Article : Google Scholar : PubMed/NCBI
|
